Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Home Dialysis Plus

Request full access

Patients and their healthcare providers with home hemodialysis solutions

Stafford, United StatesFounded 2003Health Tech & Medtech

About Home Dialysis Plus

Home Dialysis Plus, Ltd. (HD+) is a medical device company concentrated on advancing home hemodialysis treatments for individuals with end-stage renal disease. The company is developing a portable dialysis system engineered to allow for more frequent treatments, which closely mimics the natural function of kidneys and has been shown to improve a patient's quality of life. This contrasts with the standard in-clinic regimen of three four-hour sessions per week, a schedule that can be physically and emotionally demanding for patients. The HD+ system is designed to provide a gentler, nocturnal treatment, enabling patients to undergo dialysis while they sleep.

The core of the HD+ system relies on licensed and patented technologies. In 2008, the company signed an exclusive global licensing agreement with Oregon State University for its Micro-scale Energy and Chemical Systems (MECS) technology for use in blood filtration and water treatment for dialysis. MECS technology miniaturizes chemical processes using micro-channels, which enhances efficiency and significantly reduces the size of the device, making it portable. This technology is expected to decrease the required amount of dialysate and the volume of blood outside the body at any given time compared to conventional machines. The system also incorporates licensed inkjet technology from HP.

The business operates in the growing home dialysis market, which serves patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Its business model focuses on providing these patients, along with their doctors and care providers, a cost-effective and patient-friendly alternative to traditional in-clinic dialysis. By enabling treatment at home, the system offers greater flexibility and convenience. The company's revenue model will likely be based on the sale of these portable hemodialysis machines and related consumables to healthcare providers and patients. In 2010, Home Dialysis Plus secured a significant financial commitment of up to $50 million from the private equity firm Warburg Pincus to fund the commercialization of its new system. This investment followed earlier funding from the Oregon Nanoscience and Microtechnologies Institute (ONAMI) and the Oregon State Venture Fund. To accelerate development, HD+ formed a strategic partnership with StarFish Medical for product development and system integration services.

Source: Dealroom company data

At a glance

Status
Closed
Founded
2003
Headquarters
Stafford, United States
Open positions
None listed
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Biotechnology, Outside Tech, Hard Tech

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Aug 2018 $132M $528M Warburg Pincus · T. Rowe Price · Mubadala Capital ↗
SERIES COther financing May 2017 $77M $306M Warburg Pincus · Fidelity Investments · The Vertical Group · Perceptive Advisors —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Home Dialysis Plus website traffic

Latest recorded traffic for Home Dialysis Plus is 0 monthly website visits.

Latest monthly visits0
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Home Dialysis Plus in the Stafford ecosystem

Live from Dealroom

The Home Dialysis Plus office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later6 investors entered at this stage

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Stafford HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Home Dialysis Plus on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Home Dialysis Plus’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.